Long-term dual antiplatelet therapy and concomitant optimal medical therapy following percutaneous coronary intervention.
作者信息
Gargiulo Giuseppe, Valgimigli Marco
机构信息
Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Department of Advanced Biomedical Sciences, University Federico II of Naples, Naples, Italy.
出版信息
Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S102-S106. doi: 10.21037/cdt.2017.03.10.
Abstract
摘要
相似文献
1
Long-term dual antiplatelet therapy and concomitant optimal medical therapy following percutaneous coronary intervention.经皮冠状动脉介入治疗后的长期双联抗血小板治疗及同步优化药物治疗
Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S102-S106. doi: 10.21037/cdt.2017.03.10.
2
A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial.一项比较药物洗脱冠状动脉支架植入术后长期氯吡格雷与阿司匹林单药治疗（而非双联抗血小板治疗）的随机临床试验：冠状动脉狭窄治疗优化策略-延长抗血小板单药治疗（HOST-EXAM）试验的设计与原理
Am Heart J. 2017 Mar;185:17-25. doi: 10.1016/j.ahj.2016.12.001. Epub 2016 Dec 9.
3
Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysis.西洛他唑三联抗血小板治疗与标准双联抗血小板治疗在接受冠状动脉介入治疗患者中的治疗期血小板反应性比较：一项荟萃分析。
J Cardiovasc Pharmacol Ther. 2013 Nov;18(6):533-43. doi: 10.1177/1074248413495971. Epub 2013 Jul 19.
4
Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时三联抗血小板治疗与双联抗血小板治疗的比较
Circulation. 2009 Jun 30;119(25):3207-14. doi: 10.1161/CIRCULATIONAHA.108.822791. Epub 2009 Jun 15.
5
Perioperative management of dual anti-platelet therapy.双联抗血小板治疗的围手术期管理
Hosp Pract (1995). 2016 Dec;44(5):237-241. doi: 10.1080/21548331.2016.1260997. Epub 2016 Dec 4.
6
Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet Registry.双重抗血小板治疗基础上的最佳药物治疗：急性冠状动脉综合征患者的 1 年临床结局：START 抗血小板登记研究。
Angiology. 2020 Mar;71(3):235-241. doi: 10.1177/0003319719895171. Epub 2019 Dec 23.
7
Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention.经皮冠状动脉介入治疗患者双联与三联抗栓治疗的安全性和疗效。
Am J Med. 2017 Nov;130(11):1280-1289. doi: 10.1016/j.amjmed.2017.03.057. Epub 2017 Apr 29.
8
Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后双联抗血小板治疗的最佳持续时间
Interv Cardiol Clin. 2017 Jan;6(1):25-37. doi: 10.1016/j.iccl.2016.08.003.
9
Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.30毫米以上长冠状动脉病变患者的双联抗血小板治疗：决定因素及对预后的影响
Arch Cardiovasc Dis. 2015 Apr;108(4):235-43. doi: 10.1016/j.acvd.2014.11.004. Epub 2015 Feb 11.
10
Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia).支架内再狭窄治疗患者中双联抗血小板治疗的短期与长期疗程：PRODIGY 试验亚研究（在支架内内膜增生分级后延长双联抗血小板治疗）。
J Am Coll Cardiol. 2014 Feb 18;63(6):506-12. doi: 10.1016/j.jacc.2013.09.043. Epub 2013 Oct 23.
引用本文的文献
1
Antiplatelet agents in uncertain clinical scenarios-a bleeding nightmare.不确定临床情况下的抗血小板药物——一场出血噩梦。
Cardiovasc Diagn Ther. 2018 Oct;8(5):647-662. doi: 10.21037/cdt.2018.06.09.
本文引用的文献
1
Impact of chronic kidney disease on 2-year clinical outcomes in patients treated with 6-month or 24-month DAPT duration: An analysis from the PRODIGY trial.慢性肾脏病对接受6个月或24个月双联抗血小板治疗患者2年临床结局的影响：来自PRODIGY试验的分析
Catheter Cardiovasc Interv. 2017 Oct 1;90(4):E73-E84. doi: 10.1002/ccd.26921. Epub 2017 Feb 15.
2
Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial.
EuroIntervention. 2017 May 15;13(1):78-86. doi: 10.4244/EIJ-D-16-00497.
3
A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?阿司匹林在二级预防中的作用评价：少即是多？
Circulation. 2016 Dec 6;134(23):1881-1906. doi: 10.1161/CIRCULATIONAHA.116.023952.
4
Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials.糖尿病患者与非糖尿病患者药物洗脱支架植入术后短期与长期双重抗血小板治疗：来自随机试验的个体参与者数据的系统评价和荟萃分析
BMJ. 2016 Nov 3;355:i5483. doi: 10.1136/bmj.i5483.
5
Association Between Duration of Dual Antiplatelet Therapy and Angiographic Multivessel Disease on Outcomes in Patients Treated With Newer-Generation Drug-Eluting Stents.新一代药物洗脱支架治疗患者中双重抗血小板治疗持续时间与血管造影多支血管病变对预后的关联
Circ Cardiovasc Interv. 2016 Nov;9(11). doi: 10.1161/CIRCINTERVENTIONS.116.004256.
6
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.复杂 PCI 后双联抗血小板治疗的疗效和安全性。
J Am Coll Cardiol. 2016 Oct 25;68(17):1851-1864. doi: 10.1016/j.jacc.2016.07.760. Epub 2016 Aug 29.
7
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.最佳药物治疗在双联抗血小板治疗研究中的影响。
Circulation. 2016 Oct 4;134(14):989-998. doi: 10.1161/CIRCULATIONAHA.116.024531. Epub 2016 Aug 30.
8
Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial.经皮冠状动脉介入治疗患者双联抗血小板治疗时间长短与外周动脉疾病：PRODIGY 随机临床试验的亚组分析。
JAMA Cardiol. 2016 Oct 1;1(7):795-803. doi: 10.1001/jamacardio.2016.2811.
9
Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial.在接受 6 个月或 24 个月双联抗血小板治疗时长的患者中，性别对 2 年临床结局的影响：来自 PRODIGY 试验的预先设定分析。
JACC Cardiovasc Interv. 2016 Sep 12;9(17):1780-9. doi: 10.1016/j.jcin.2016.05.046. Epub 2016 Aug 17.
10
Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials.药物洗脱支架植入术后女性与男性短期与长期双重抗血小板治疗：六项随机试验的性别特异性患者水平汇总分析。
Catheter Cardiovasc Interv. 2017 Feb 1;89(2):178-189. doi: 10.1002/ccd.26653. Epub 2016 Jul 18.
Zotero 插件